MCRA offers strategic, operational consulting, and call center solutions in a challenging healthcare environment to ensure a positive reimbursement experience. Medical billing, coding and reimbursement requires the same attention as other departments, such as sales, marketing, finance, accounting, clinical, and regulatory.
Contact an ivd device reimbursement Expert
IVD Device Experience
MCRA focuses on assisting clients on a daily basis to ensure appropriate coverage and reimbursement for medical procedures and medical devices. Key IVD device areas of expertise include:
- Anemia in vitro diagnostics
- Antimicrobial resistance marker genetic in vitro diagnostics
- Antimicrobial susceptibility (AST) in vitro diagnostics
- Autoimmune disorder in vitro diagnostics
- Bacterial infection in vitro diagnostics
- Blood clotting disorder in vitro diagnostics
- Breath in vitro diagnostics
- Cancer in vitro diagnostics
- Cancer monitoring in vitro diagnostics
- Cancer Predisposition Risk Assessment in vitro diagnostics
- Cardiovascular disease in vitro diagnostics
- Chemistry analyte in vitro diagnostics
- Companion Diagnostic (CDx) in vitro diagnostics
- Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection in vitro diagnostics
- Diabetes in vitro diagnostics
- Digital Pathology in vitro diagnostics
- Drugs of abuse in vitro diagnostics
- Fever-causing infection in vitro diagnostics
- Food and other allergy in vitro diagnostics
- Fungal infection in vitro diagnostics
- Gastrointestinal bleeding in vitro diagnostics
- Gastrointestinal pathogens in vitro diagnostics
- Gene expression profiling in vitro diagnostics
- Gene expression profiling test system in vitro diagnostics
- Genetic health risk (GHR) in vitro diagnostics
- Heavy metal in vitro diagnostics
- Immune deficiency in vitro diagnostics
- Immunoglobulin light chain amyloidosis in vitro diagnostics
- Immunohistochemistry (IHC) in vitro diagnostics
- In vitro diagnostic instrumentation
- In vitro diagnostics supported by over the counter (OTC), point of care (POC), or CLIA waiver studies
- Infectious disease in vitro diagnostics
- Latent viral infection in vitro diagnostics
- Liquid biopsy in vitro diagnostics
- Medical Countermeasure in vitro diagnostics
- Minimal Residual Disease (MRD)/tumor burden in vitro diagnostics
- Neural tube defects in vitro diagnostics
- Next generation sequencing based tumor mutation profiling in vitro diagnostics
- Organ damage/disfunction in vitro diagnostics
- Pharmacogenetic/Pharmacogenomic in vitro diagnostics
- Postnatal chromosomal copy number variation detection in vitro diagnostics
- Primary hemostatic function in vitro diagnostics
- Respiratory pathogens in vitro diagnostics
- Semen analysis in vitro diagnostics
- Sepsis and septic shock prognosis in vitro diagnostics
- Sexually transmitted disease in vitro diagnostics
- Specimen collection devices
- Therapeutic Drug Monitoring (TDM) in vitro diagnostics
- Traumatic brain injury (TBI) in vitro diagnostics
- Viral infection in vitro diagnostics
- Women’s health in vitro diagnostics
Reimbursement Services
MCRA’s coding, reimbursement, and compliance experts have over 50 years of combined healthcare policy and finance services experience and have a proven track record servicing over 250 clients nationwide.
Our comprehensive reimbursement, health economics and public policy services include:
- Call center – coding and coverage access
- Clinical trial reimbursement
- Coding analysis and assessments
- Coding hotline
- Healthcare economics
- Medical billing and coding
- Medical reimbursement
- Payor outreach
- Reimbursement resource guides
- Strategic reimbursement